Nanostics Prostate Cancer Screening Test, ClarityDX Prostate®, becomes accessible to men in British Columbia, Saskatchewan, and Ontario
Discover Why Health Professionals Trust NanoSALV Catalytic from NanoTess – a Novel, Cost-Effective Canadian Wound Care Technology
Nanostics and AHS collaborate to develop new diagnostic tools for urological diseases
FREDsense Launches Advanced Rapid Testing PFAS Analytical Services
Local AI non-profit organization to receive grant from Google Canada.
